Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016-2022).

The Lancet regional health. Southeast Asia·2026

Same author

Efficacy and Safety of Bruton Tyrosine Kinase Inhibitors in Waldenström Macroglobulinemia: A Single-Center Retrospective Analysis.

Cureus·2026

Same author

Optimizing Treatment-Free Remission (TFR) in Chronic Myeloid Leukemia: Challenges and a Modified Monitoring Strategy - Real-World Data from Eastern India.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026

Same author

Addressing the Global Diagnostics Gap for Childhood Leukemias: A Global, Multisite Type 2 Hybrid Validation Study of Nanopore-based Adaptive Sampling Whole Genome Sequencing.

medRxiv : the preprint server for health sciences·2026

Same author

Development of a face-validated conceptual model structure for economic evaluation in phenylketonuria, through expert elicitation.

Orphanet journal of rare diseases·2026

Same author

POLE mutations in endometrial carcinoma from a tertiary cancer care centre in eastern India.

The Indian journal of medical research·2026

Search research articles

Related Experiment Video

Updated: Apr 12, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Plasma cell leukaemia: a management conundrum.

Sriram Ravichandran¹, Monali Gupta², Mayur Parihar³

¹Department of Clinical Haematology , Tata Medical Center , Kolkata , India.

Oxford Medical Case Reports

|May 20, 2015

Summary

Primary plasma cell leukaemia in young patients presents management challenges. The optimal transplant strategy, autologous versus allogeneic haematopoietic stem cell transplant, remains unclear for achieving remission.

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

Related Experiment Videos

Last Updated: Apr 12, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

Area of Science:

Hematology
Oncology

Background:

Primary plasma cell leukaemia (PCL) is a rare and aggressive plasma cell dyscrasia.
Optimal treatment strategies for young, transplant-eligible PCL patients are not well-defined.

Observation:

This case report details the management of a young patient with primary plasma cell leukaemia.
The patient was eligible for haematopoietic stem cell transplantation.

Findings:

Novel agents show promise over conventional chemotherapy for PCL.
The choice between autologous and allogeneic haematopoietic stem cell transplant in first remission poses a significant therapeutic dilemma.

Implications:

This case highlights the complex decision-making process in managing young PCL patients.
Further research is needed to clarify the optimal transplant approach for primary plasma cell leukaemia.